nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—ABCG2—Vismodegib—skin cancer	0.0951	0.119	CbGbCtD
Pravastatin—ABCG2—Vemurafenib—skin cancer	0.0752	0.0943	CbGbCtD
Pravastatin—SLC22A7—Fluorouracil—skin cancer	0.0643	0.0806	CbGbCtD
Pravastatin—SLCO1B3—Docetaxel—skin cancer	0.0558	0.0699	CbGbCtD
Pravastatin—CYP2C8—Vismodegib—skin cancer	0.0507	0.0636	CbGbCtD
Pravastatin—ABCG2—Dactinomycin—skin cancer	0.05	0.0627	CbGbCtD
Pravastatin—SLC22A7—Docetaxel—skin cancer	0.0491	0.0616	CbGbCtD
Pravastatin—CYP2C9—Vismodegib—skin cancer	0.0354	0.0443	CbGbCtD
Pravastatin—ABCB1—Vismodegib—skin cancer	0.0343	0.043	CbGbCtD
Pravastatin—ABCG2—Fluorouracil—skin cancer	0.0338	0.0424	CbGbCtD
Pravastatin—CYP3A4—Temozolomide—skin cancer	0.0297	0.0372	CbGbCtD
Pravastatin—CYP3A4—Imiquimod—skin cancer	0.0297	0.0372	CbGbCtD
Pravastatin—ABCC2—Docetaxel—skin cancer	0.0285	0.0358	CbGbCtD
Pravastatin—ABCG2—Docetaxel—skin cancer	0.0258	0.0324	CbGbCtD
Pravastatin—CYP2D6—Vemurafenib—skin cancer	0.0256	0.032	CbGbCtD
Pravastatin—CYP3A4—Vismodegib—skin cancer	0.0206	0.0258	CbGbCtD
Pravastatin—ABCB1—Dactinomycin—skin cancer	0.018	0.0226	CbGbCtD
Pravastatin—CYP2C8—Fluorouracil—skin cancer	0.018	0.0226	CbGbCtD
Pravastatin—CYP3A4—Vemurafenib—skin cancer	0.0162	0.0204	CbGbCtD
Pravastatin—CYP3A5—Docetaxel—skin cancer	0.0143	0.0179	CbGbCtD
Pravastatin—CYP2C9—Fluorouracil—skin cancer	0.0126	0.0157	CbGbCtD
Pravastatin—ABCB1—Docetaxel—skin cancer	0.00931	0.0117	CbGbCtD
Pravastatin—CYP3A4—Docetaxel—skin cancer	0.00558	0.00699	CbGbCtD
Pravastatin—HMGCR—Sorafenib—Vismodegib—skin cancer	0.0049	1	CbGdCrCtD
Pravastatin—Alopecia—Bleomycin—skin cancer	0.000364	0.00185	CcSEcCtD
Pravastatin—Erythema multiforme—Dactinomycin—skin cancer	0.000364	0.00185	CcSEcCtD
Pravastatin—Sinusitis—Temozolomide—skin cancer	0.000364	0.00185	CcSEcCtD
Pravastatin—Dyspepsia—Imiquimod—skin cancer	0.000363	0.00185	CcSEcCtD
Pravastatin—Decreased appetite—Imiquimod—skin cancer	0.000359	0.00182	CcSEcCtD
Pravastatin—Hot flush—Docetaxel—skin cancer	0.000358	0.00182	CcSEcCtD
Pravastatin—Flushing—Dactinomycin—skin cancer	0.000357	0.00182	CcSEcCtD
Pravastatin—Hypersensitivity—Vemurafenib—skin cancer	0.000356	0.00181	CcSEcCtD
Pravastatin—Fatigue—Imiquimod—skin cancer	0.000356	0.00181	CcSEcCtD
Pravastatin—Menopausal symptoms—Docetaxel—skin cancer	0.000354	0.0018	CcSEcCtD
Pravastatin—Pain—Imiquimod—skin cancer	0.000353	0.00179	CcSEcCtD
Pravastatin—Acute coronary syndrome—Fluorouracil—skin cancer	0.000352	0.00179	CcSEcCtD
Pravastatin—Myocardial infarction—Fluorouracil—skin cancer	0.00035	0.00178	CcSEcCtD
Pravastatin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00035	0.00178	CcSEcCtD
Pravastatin—Hepatitis—Temozolomide—skin cancer	0.000348	0.00177	CcSEcCtD
Pravastatin—Urinary tract infection—Fluorouracil—skin cancer	0.000347	0.00177	CcSEcCtD
Pravastatin—Asthenia—Vemurafenib—skin cancer	0.000347	0.00177	CcSEcCtD
Pravastatin—Hypoaesthesia—Temozolomide—skin cancer	0.000346	0.00176	CcSEcCtD
Pravastatin—Pharyngitis—Temozolomide—skin cancer	0.000345	0.00176	CcSEcCtD
Pravastatin—Chills—Dactinomycin—skin cancer	0.000345	0.00176	CcSEcCtD
Pravastatin—Pruritus—Vemurafenib—skin cancer	0.000342	0.00174	CcSEcCtD
Pravastatin—Alopecia—Dactinomycin—skin cancer	0.00034	0.00173	CcSEcCtD
Pravastatin—Feeling abnormal—Imiquimod—skin cancer	0.00034	0.00173	CcSEcCtD
Pravastatin—Gastrointestinal pain—Imiquimod—skin cancer	0.000337	0.00172	CcSEcCtD
Pravastatin—Visual impairment—Temozolomide—skin cancer	0.000335	0.00171	CcSEcCtD
Pravastatin—Sinusitis—Fluorouracil—skin cancer	0.000335	0.0017	CcSEcCtD
Pravastatin—Ill-defined disorder—Bleomycin—skin cancer	0.000333	0.00169	CcSEcCtD
Pravastatin—Anaemia—Bleomycin—skin cancer	0.000332	0.00169	CcSEcCtD
Pravastatin—Diarrhoea—Vemurafenib—skin cancer	0.000331	0.00168	CcSEcCtD
Pravastatin—Erythema multiforme—Temozolomide—skin cancer	0.000329	0.00167	CcSEcCtD
Pravastatin—Urticaria—Imiquimod—skin cancer	0.000328	0.00167	CcSEcCtD
Pravastatin—Abdominal pain—Imiquimod—skin cancer	0.000326	0.00166	CcSEcCtD
Pravastatin—Body temperature increased—Imiquimod—skin cancer	0.000326	0.00166	CcSEcCtD
Pravastatin—Tinnitus—Temozolomide—skin cancer	0.000324	0.00165	CcSEcCtD
Pravastatin—Malaise—Bleomycin—skin cancer	0.000324	0.00165	CcSEcCtD
Pravastatin—Flushing—Temozolomide—skin cancer	0.000323	0.00164	CcSEcCtD
Pravastatin—Cardiac disorder—Temozolomide—skin cancer	0.000323	0.00164	CcSEcCtD
Pravastatin—Leukopenia—Bleomycin—skin cancer	0.000321	0.00163	CcSEcCtD
Pravastatin—Rhinitis—Fluorouracil—skin cancer	0.000321	0.00163	CcSEcCtD
Pravastatin—Dizziness—Vemurafenib—skin cancer	0.00032	0.00163	CcSEcCtD
Pravastatin—Hypoaesthesia—Fluorouracil—skin cancer	0.000319	0.00162	CcSEcCtD
Pravastatin—Pharyngitis—Fluorouracil—skin cancer	0.000318	0.00162	CcSEcCtD
Pravastatin—Cough—Bleomycin—skin cancer	0.000313	0.00159	CcSEcCtD
Pravastatin—Chills—Temozolomide—skin cancer	0.000312	0.00159	CcSEcCtD
Pravastatin—Ill-defined disorder—Dactinomycin—skin cancer	0.000311	0.00158	CcSEcCtD
Pravastatin—Anaemia—Dactinomycin—skin cancer	0.00031	0.00157	CcSEcCtD
Pravastatin—Liver function test abnormal—Docetaxel—skin cancer	0.000309	0.00157	CcSEcCtD
Pravastatin—Vomiting—Vemurafenib—skin cancer	0.000308	0.00156	CcSEcCtD
Pravastatin—Alopecia—Temozolomide—skin cancer	0.000307	0.00156	CcSEcCtD
Pravastatin—Dry skin—Docetaxel—skin cancer	0.000307	0.00156	CcSEcCtD
Pravastatin—Chest pain—Bleomycin—skin cancer	0.000306	0.00155	CcSEcCtD
Pravastatin—Myalgia—Bleomycin—skin cancer	0.000306	0.00155	CcSEcCtD
Pravastatin—Rash—Vemurafenib—skin cancer	0.000305	0.00155	CcSEcCtD
Pravastatin—Dermatitis—Vemurafenib—skin cancer	0.000305	0.00155	CcSEcCtD
Pravastatin—Hypersensitivity—Imiquimod—skin cancer	0.000304	0.00155	CcSEcCtD
Pravastatin—Headache—Vemurafenib—skin cancer	0.000303	0.00154	CcSEcCtD
Pravastatin—Discomfort—Bleomycin—skin cancer	0.000302	0.00154	CcSEcCtD
Pravastatin—Malaise—Dactinomycin—skin cancer	0.000302	0.00154	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000301	0.00153	CcSEcCtD
Pravastatin—Cramp muscle—Docetaxel—skin cancer	0.000301	0.00153	CcSEcCtD
Pravastatin—Leukopenia—Dactinomycin—skin cancer	0.0003	0.00152	CcSEcCtD
Pravastatin—Nasopharyngitis—Docetaxel—skin cancer	0.000299	0.00152	CcSEcCtD
Pravastatin—Dysgeusia—Temozolomide—skin cancer	0.000297	0.00151	CcSEcCtD
Pravastatin—Asthenia—Imiquimod—skin cancer	0.000296	0.00151	CcSEcCtD
Pravastatin—Confusional state—Bleomycin—skin cancer	0.000295	0.0015	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000295	0.0015	CcSEcCtD
Pravastatin—Anaphylactic shock—Bleomycin—skin cancer	0.000293	0.00149	CcSEcCtD
Pravastatin—Oedema—Bleomycin—skin cancer	0.000293	0.00149	CcSEcCtD
Pravastatin—Pruritus—Imiquimod—skin cancer	0.000292	0.00148	CcSEcCtD
Pravastatin—Infection—Bleomycin—skin cancer	0.000291	0.00148	CcSEcCtD
Pravastatin—Nausea—Vemurafenib—skin cancer	0.000287	0.00146	CcSEcCtD
Pravastatin—Thrombocytopenia—Bleomycin—skin cancer	0.000287	0.00146	CcSEcCtD
Pravastatin—Arrhythmia—Fluorouracil—skin cancer	0.000286	0.00146	CcSEcCtD
Pravastatin—Vision blurred—Temozolomide—skin cancer	0.000285	0.00145	CcSEcCtD
Pravastatin—Myalgia—Dactinomycin—skin cancer	0.000285	0.00145	CcSEcCtD
Pravastatin—Tremor—Temozolomide—skin cancer	0.000284	0.00144	CcSEcCtD
Pravastatin—Alopecia—Fluorouracil—skin cancer	0.000283	0.00144	CcSEcCtD
Pravastatin—Diarrhoea—Imiquimod—skin cancer	0.000282	0.00144	CcSEcCtD
Pravastatin—Discomfort—Dactinomycin—skin cancer	0.000282	0.00143	CcSEcCtD
Pravastatin—Angina pectoris—Docetaxel—skin cancer	0.000282	0.00143	CcSEcCtD
Pravastatin—Ill-defined disorder—Temozolomide—skin cancer	0.000281	0.00143	CcSEcCtD
Pravastatin—Anaemia—Temozolomide—skin cancer	0.00028	0.00142	CcSEcCtD
Pravastatin—Anorexia—Bleomycin—skin cancer	0.000279	0.00142	CcSEcCtD
Pravastatin—Angioedema—Temozolomide—skin cancer	0.000277	0.00141	CcSEcCtD
Pravastatin—Oedema—Dactinomycin—skin cancer	0.000273	0.00139	CcSEcCtD
Pravastatin—Malaise—Temozolomide—skin cancer	0.000273	0.00139	CcSEcCtD
Pravastatin—Dizziness—Imiquimod—skin cancer	0.000273	0.00139	CcSEcCtD
Pravastatin—Vertigo—Temozolomide—skin cancer	0.000272	0.00138	CcSEcCtD
Pravastatin—Infection—Dactinomycin—skin cancer	0.000272	0.00138	CcSEcCtD
Pravastatin—Leukopenia—Temozolomide—skin cancer	0.000271	0.00138	CcSEcCtD
Pravastatin—Thrombocytopenia—Dactinomycin—skin cancer	0.000268	0.00136	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000267	0.00136	CcSEcCtD
Pravastatin—Cough—Temozolomide—skin cancer	0.000264	0.00134	CcSEcCtD
Pravastatin—Paraesthesia—Bleomycin—skin cancer	0.000263	0.00134	CcSEcCtD
Pravastatin—Weight increased—Docetaxel—skin cancer	0.000263	0.00134	CcSEcCtD
Pravastatin—Vision blurred—Fluorouracil—skin cancer	0.000263	0.00134	CcSEcCtD
Pravastatin—Vomiting—Imiquimod—skin cancer	0.000262	0.00133	CcSEcCtD
Pravastatin—Weight decreased—Docetaxel—skin cancer	0.000262	0.00133	CcSEcCtD
Pravastatin—Hypertension—Temozolomide—skin cancer	0.000261	0.00133	CcSEcCtD
Pravastatin—Dyspnoea—Bleomycin—skin cancer	0.000261	0.00133	CcSEcCtD
Pravastatin—Anorexia—Dactinomycin—skin cancer	0.000261	0.00133	CcSEcCtD
Pravastatin—Rash—Imiquimod—skin cancer	0.00026	0.00132	CcSEcCtD
Pravastatin—Dermatitis—Imiquimod—skin cancer	0.00026	0.00132	CcSEcCtD
Pravastatin—Headache—Imiquimod—skin cancer	0.000258	0.00131	CcSEcCtD
Pravastatin—Anaemia—Fluorouracil—skin cancer	0.000258	0.00131	CcSEcCtD
Pravastatin—Arthralgia—Temozolomide—skin cancer	0.000258	0.00131	CcSEcCtD
Pravastatin—Myalgia—Temozolomide—skin cancer	0.000258	0.00131	CcSEcCtD
Pravastatin—Anxiety—Temozolomide—skin cancer	0.000257	0.00131	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000256	0.0013	CcSEcCtD
Pravastatin—Discomfort—Temozolomide—skin cancer	0.000255	0.0013	CcSEcCtD
Pravastatin—Decreased appetite—Bleomycin—skin cancer	0.000255	0.0013	CcSEcCtD
Pravastatin—Acute coronary syndrome—Docetaxel—skin cancer	0.000254	0.00129	CcSEcCtD
Pravastatin—Myocardial infarction—Docetaxel—skin cancer	0.000253	0.00129	CcSEcCtD
Pravastatin—Neuropathy peripheral—Docetaxel—skin cancer	0.000253	0.00129	CcSEcCtD
Pravastatin—Jaundice—Docetaxel—skin cancer	0.000251	0.00128	CcSEcCtD
Pravastatin—Pain—Bleomycin—skin cancer	0.000251	0.00127	CcSEcCtD
Pravastatin—Leukopenia—Fluorouracil—skin cancer	0.00025	0.00127	CcSEcCtD
Pravastatin—Confusional state—Temozolomide—skin cancer	0.000249	0.00127	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000249	0.00127	CcSEcCtD
Pravastatin—Anaphylactic shock—Temozolomide—skin cancer	0.000247	0.00126	CcSEcCtD
Pravastatin—Oedema—Temozolomide—skin cancer	0.000247	0.00126	CcSEcCtD
Pravastatin—Infection—Temozolomide—skin cancer	0.000246	0.00125	CcSEcCtD
Pravastatin—Nausea—Imiquimod—skin cancer	0.000245	0.00125	CcSEcCtD
Pravastatin—Thrombocytopenia—Temozolomide—skin cancer	0.000242	0.00123	CcSEcCtD
Pravastatin—Feeling abnormal—Bleomycin—skin cancer	0.000241	0.00123	CcSEcCtD
Pravastatin—Hyperhidrosis—Temozolomide—skin cancer	0.000239	0.00122	CcSEcCtD
Pravastatin—Chest pain—Fluorouracil—skin cancer	0.000238	0.00121	CcSEcCtD
Pravastatin—Myalgia—Fluorouracil—skin cancer	0.000238	0.00121	CcSEcCtD
Pravastatin—Decreased appetite—Dactinomycin—skin cancer	0.000238	0.00121	CcSEcCtD
Pravastatin—Fatigue—Dactinomycin—skin cancer	0.000236	0.0012	CcSEcCtD
Pravastatin—Anorexia—Temozolomide—skin cancer	0.000236	0.0012	CcSEcCtD
Pravastatin—Discomfort—Fluorouracil—skin cancer	0.000235	0.00119	CcSEcCtD
Pravastatin—Pain—Dactinomycin—skin cancer	0.000234	0.00119	CcSEcCtD
Pravastatin—Urticaria—Bleomycin—skin cancer	0.000233	0.00118	CcSEcCtD
Pravastatin—Rhinitis—Docetaxel—skin cancer	0.000232	0.00118	CcSEcCtD
Pravastatin—Body temperature increased—Bleomycin—skin cancer	0.000232	0.00118	CcSEcCtD
Pravastatin—Hepatitis—Docetaxel—skin cancer	0.000231	0.00118	CcSEcCtD
Pravastatin—Hypoaesthesia—Docetaxel—skin cancer	0.00023	0.00117	CcSEcCtD
Pravastatin—Confusional state—Fluorouracil—skin cancer	0.00023	0.00117	CcSEcCtD
Pravastatin—Pharyngitis—Docetaxel—skin cancer	0.00023	0.00117	CcSEcCtD
Pravastatin—Anaphylactic shock—Fluorouracil—skin cancer	0.000228	0.00116	CcSEcCtD
Pravastatin—Oedema—Fluorouracil—skin cancer	0.000228	0.00116	CcSEcCtD
Pravastatin—Infection—Fluorouracil—skin cancer	0.000226	0.00115	CcSEcCtD
Pravastatin—Feeling abnormal—Dactinomycin—skin cancer	0.000225	0.00115	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000225	0.00115	CcSEcCtD
Pravastatin—Insomnia—Temozolomide—skin cancer	0.000224	0.00114	CcSEcCtD
Pravastatin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000223	0.00114	CcSEcCtD
Pravastatin—Thrombocytopenia—Fluorouracil—skin cancer	0.000223	0.00113	CcSEcCtD
Pravastatin—Visual impairment—Docetaxel—skin cancer	0.000223	0.00113	CcSEcCtD
Pravastatin—Paraesthesia—Temozolomide—skin cancer	0.000222	0.00113	CcSEcCtD
Pravastatin—Dyspnoea—Temozolomide—skin cancer	0.00022	0.00112	CcSEcCtD
Pravastatin—Erythema multiforme—Docetaxel—skin cancer	0.000219	0.00111	CcSEcCtD
Pravastatin—Dyspepsia—Temozolomide—skin cancer	0.000218	0.00111	CcSEcCtD
Pravastatin—Anorexia—Fluorouracil—skin cancer	0.000217	0.0011	CcSEcCtD
Pravastatin—Abdominal pain—Dactinomycin—skin cancer	0.000216	0.0011	CcSEcCtD
Pravastatin—Body temperature increased—Dactinomycin—skin cancer	0.000216	0.0011	CcSEcCtD
Pravastatin—Hypersensitivity—Bleomycin—skin cancer	0.000216	0.0011	CcSEcCtD
Pravastatin—Decreased appetite—Temozolomide—skin cancer	0.000215	0.00109	CcSEcCtD
Pravastatin—Cardiac disorder—Docetaxel—skin cancer	0.000215	0.00109	CcSEcCtD
Pravastatin—Flushing—Docetaxel—skin cancer	0.000215	0.00109	CcSEcCtD
Pravastatin—Fatigue—Temozolomide—skin cancer	0.000213	0.00108	CcSEcCtD
Pravastatin—Pain—Temozolomide—skin cancer	0.000211	0.00108	CcSEcCtD
Pravastatin—Constipation—Temozolomide—skin cancer	0.000211	0.00108	CcSEcCtD
Pravastatin—Asthenia—Bleomycin—skin cancer	0.00021	0.00107	CcSEcCtD
Pravastatin—Chills—Docetaxel—skin cancer	0.000208	0.00106	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000208	0.00106	CcSEcCtD
Pravastatin—Pruritus—Bleomycin—skin cancer	0.000207	0.00105	CcSEcCtD
Pravastatin—Arrhythmia—Docetaxel—skin cancer	0.000207	0.00105	CcSEcCtD
Pravastatin—Insomnia—Fluorouracil—skin cancer	0.000206	0.00105	CcSEcCtD
Pravastatin—Paraesthesia—Fluorouracil—skin cancer	0.000205	0.00104	CcSEcCtD
Pravastatin—Alopecia—Docetaxel—skin cancer	0.000204	0.00104	CcSEcCtD
Pravastatin—Feeling abnormal—Temozolomide—skin cancer	0.000204	0.00104	CcSEcCtD
Pravastatin—Dyspnoea—Fluorouracil—skin cancer	0.000203	0.00103	CcSEcCtD
Pravastatin—Gastrointestinal pain—Temozolomide—skin cancer	0.000202	0.00103	CcSEcCtD
Pravastatin—Hypersensitivity—Dactinomycin—skin cancer	0.000201	0.00102	CcSEcCtD
Pravastatin—Dyspepsia—Fluorouracil—skin cancer	0.0002	0.00102	CcSEcCtD
Pravastatin—Decreased appetite—Fluorouracil—skin cancer	0.000198	0.00101	CcSEcCtD
Pravastatin—Dysgeusia—Docetaxel—skin cancer	0.000197	0.001	CcSEcCtD
Pravastatin—Urticaria—Temozolomide—skin cancer	0.000196	0.000999	CcSEcCtD
Pravastatin—Asthenia—Dactinomycin—skin cancer	0.000196	0.000997	CcSEcCtD
Pravastatin—Body temperature increased—Temozolomide—skin cancer	0.000195	0.000994	CcSEcCtD
Pravastatin—Abdominal pain—Temozolomide—skin cancer	0.000195	0.000994	CcSEcCtD
Pravastatin—Pain—Fluorouracil—skin cancer	0.000195	0.000991	CcSEcCtD
Pravastatin—Muscle spasms—Docetaxel—skin cancer	0.000194	0.000985	CcSEcCtD
Pravastatin—Feeling abnormal—Fluorouracil—skin cancer	0.000188	0.000955	CcSEcCtD
Pravastatin—Diarrhoea—Dactinomycin—skin cancer	0.000187	0.000951	CcSEcCtD
Pravastatin—Vomiting—Bleomycin—skin cancer	0.000186	0.000948	CcSEcCtD
Pravastatin—Anaemia—Docetaxel—skin cancer	0.000186	0.000947	CcSEcCtD
Pravastatin—Rash—Bleomycin—skin cancer	0.000185	0.00094	CcSEcCtD
Pravastatin—Dermatitis—Bleomycin—skin cancer	0.000185	0.000939	CcSEcCtD
Pravastatin—Hypersensitivity—Temozolomide—skin cancer	0.000182	0.000926	CcSEcCtD
Pravastatin—Urticaria—Fluorouracil—skin cancer	0.000181	0.00092	CcSEcCtD
Pravastatin—Leukopenia—Docetaxel—skin cancer	0.00018	0.000917	CcSEcCtD
Pravastatin—Body temperature increased—Fluorouracil—skin cancer	0.00018	0.000916	CcSEcCtD
Pravastatin—Asthenia—Temozolomide—skin cancer	0.000177	0.000902	CcSEcCtD
Pravastatin—Cough—Docetaxel—skin cancer	0.000176	0.000894	CcSEcCtD
Pravastatin—Pruritus—Temozolomide—skin cancer	0.000175	0.00089	CcSEcCtD
Pravastatin—Nausea—Bleomycin—skin cancer	0.000174	0.000885	CcSEcCtD
Pravastatin—Hypertension—Docetaxel—skin cancer	0.000174	0.000885	CcSEcCtD
Pravastatin—Vomiting—Dactinomycin—skin cancer	0.000174	0.000884	CcSEcCtD
Pravastatin—Rash—Dactinomycin—skin cancer	0.000172	0.000877	CcSEcCtD
Pravastatin—Arthralgia—Docetaxel—skin cancer	0.000171	0.000872	CcSEcCtD
Pravastatin—Chest pain—Docetaxel—skin cancer	0.000171	0.000872	CcSEcCtD
Pravastatin—Myalgia—Docetaxel—skin cancer	0.000171	0.000872	CcSEcCtD
Pravastatin—Diarrhoea—Temozolomide—skin cancer	0.000169	0.00086	CcSEcCtD
Pravastatin—Hypersensitivity—Fluorouracil—skin cancer	0.000168	0.000854	CcSEcCtD
Pravastatin—Confusional state—Docetaxel—skin cancer	0.000166	0.000843	CcSEcCtD
Pravastatin—Anaphylactic shock—Docetaxel—skin cancer	0.000164	0.000836	CcSEcCtD
Pravastatin—Oedema—Docetaxel—skin cancer	0.000164	0.000836	CcSEcCtD
Pravastatin—Dizziness—Temozolomide—skin cancer	0.000163	0.000831	CcSEcCtD
Pravastatin—Infection—Docetaxel—skin cancer	0.000163	0.000831	CcSEcCtD
Pravastatin—Nausea—Dactinomycin—skin cancer	0.000162	0.000826	CcSEcCtD
Pravastatin—Pruritus—Fluorouracil—skin cancer	0.000161	0.00082	CcSEcCtD
Pravastatin—Thrombocytopenia—Docetaxel—skin cancer	0.000161	0.000819	CcSEcCtD
Pravastatin—Vomiting—Temozolomide—skin cancer	0.000157	0.000799	CcSEcCtD
Pravastatin—Anorexia—Docetaxel—skin cancer	0.000157	0.000797	CcSEcCtD
Pravastatin—Rash—Temozolomide—skin cancer	0.000156	0.000793	CcSEcCtD
Pravastatin—Diarrhoea—Fluorouracil—skin cancer	0.000156	0.000793	CcSEcCtD
Pravastatin—Dermatitis—Temozolomide—skin cancer	0.000156	0.000792	CcSEcCtD
Pravastatin—Headache—Temozolomide—skin cancer	0.000155	0.000788	CcSEcCtD
Pravastatin—Dizziness—Fluorouracil—skin cancer	0.000151	0.000766	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00015	0.000762	CcSEcCtD
Pravastatin—Insomnia—Docetaxel—skin cancer	0.000149	0.000756	CcSEcCtD
Pravastatin—Paraesthesia—Docetaxel—skin cancer	0.000148	0.000751	CcSEcCtD
Pravastatin—Nausea—Temozolomide—skin cancer	0.000147	0.000747	CcSEcCtD
Pravastatin—Dyspnoea—Docetaxel—skin cancer	0.000147	0.000745	CcSEcCtD
Pravastatin—Vomiting—Fluorouracil—skin cancer	0.000145	0.000737	CcSEcCtD
Pravastatin—Dyspepsia—Docetaxel—skin cancer	0.000145	0.000736	CcSEcCtD
Pravastatin—Rash—Fluorouracil—skin cancer	0.000144	0.00073	CcSEcCtD
Pravastatin—Dermatitis—Fluorouracil—skin cancer	0.000143	0.00073	CcSEcCtD
Pravastatin—Decreased appetite—Docetaxel—skin cancer	0.000143	0.000727	CcSEcCtD
Pravastatin—Headache—Fluorouracil—skin cancer	0.000143	0.000726	CcSEcCtD
Pravastatin—Fatigue—Docetaxel—skin cancer	0.000142	0.000721	CcSEcCtD
Pravastatin—Constipation—Docetaxel—skin cancer	0.000141	0.000715	CcSEcCtD
Pravastatin—Pain—Docetaxel—skin cancer	0.000141	0.000715	CcSEcCtD
Pravastatin—Feeling abnormal—Docetaxel—skin cancer	0.000135	0.000689	CcSEcCtD
Pravastatin—Nausea—Fluorouracil—skin cancer	0.000135	0.000688	CcSEcCtD
Pravastatin—Gastrointestinal pain—Docetaxel—skin cancer	0.000134	0.000684	CcSEcCtD
Pravastatin—Abdominal pain—Docetaxel—skin cancer	0.00013	0.000661	CcSEcCtD
Pravastatin—Body temperature increased—Docetaxel—skin cancer	0.00013	0.000661	CcSEcCtD
Pravastatin—Hypersensitivity—Docetaxel—skin cancer	0.000121	0.000616	CcSEcCtD
Pravastatin—Asthenia—Docetaxel—skin cancer	0.000118	0.0006	CcSEcCtD
Pravastatin—Pruritus—Docetaxel—skin cancer	0.000116	0.000592	CcSEcCtD
Pravastatin—Diarrhoea—Docetaxel—skin cancer	0.000112	0.000572	CcSEcCtD
Pravastatin—Dizziness—Docetaxel—skin cancer	0.000109	0.000553	CcSEcCtD
Pravastatin—Vomiting—Docetaxel—skin cancer	0.000105	0.000532	CcSEcCtD
Pravastatin—Rash—Docetaxel—skin cancer	0.000104	0.000527	CcSEcCtD
Pravastatin—Dermatitis—Docetaxel—skin cancer	0.000104	0.000527	CcSEcCtD
Pravastatin—Headache—Docetaxel—skin cancer	0.000103	0.000524	CcSEcCtD
Pravastatin—Nausea—Docetaxel—skin cancer	9.76e-05	0.000497	CcSEcCtD
Pravastatin—HMGCR—hair follicle—skin cancer	9.32e-05	0.0941	CbGeAlD
Pravastatin—HMGCR—nipple—skin cancer	6.32e-05	0.0638	CbGeAlD
Pravastatin—HMGCR—neck—skin cancer	6.25e-05	0.0631	CbGeAlD
Pravastatin—HMGCR—connective tissue—skin cancer	4.48e-05	0.0452	CbGeAlD
Pravastatin—HMGCR—epithelium—skin cancer	4.26e-05	0.043	CbGeAlD
Pravastatin—SLC16A1—epithelium—skin cancer	4.19e-05	0.0423	CbGeAlD
Pravastatin—SLC22A11—female reproductive system—skin cancer	4.17e-05	0.0421	CbGeAlD
Pravastatin—HMGCR—skin of body—skin cancer	4.05e-05	0.0409	CbGeAlD
Pravastatin—HMGCR—mammalian vulva—skin cancer	3.69e-05	0.0373	CbGeAlD
Pravastatin—HMGCR—lymphoid tissue—skin cancer	3.28e-05	0.0331	CbGeAlD
Pravastatin—HMGCR—female reproductive system—skin cancer	3.16e-05	0.0319	CbGeAlD
Pravastatin—SLC16A1—female reproductive system—skin cancer	3.11e-05	0.0314	CbGeAlD
Pravastatin—SLCO1B1—female reproductive system—skin cancer	3.03e-05	0.0306	CbGeAlD
Pravastatin—SLCO2B1—female reproductive system—skin cancer	2.68e-05	0.027	CbGeAlD
Pravastatin—HMGCR—head—skin cancer	2.64e-05	0.0267	CbGeAlD
Pravastatin—SLC16A1—head—skin cancer	2.6e-05	0.0263	CbGeAlD
Pravastatin—ABCC2—female reproductive system—skin cancer	2.3e-05	0.0232	CbGeAlD
Pravastatin—ABCB1—blood vessel—skin cancer	2.28e-05	0.023	CbGeAlD
Pravastatin—SLCO2B1—head—skin cancer	2.24e-05	0.0226	CbGeAlD
Pravastatin—SLCO1A2—head—skin cancer	2.06e-05	0.0208	CbGeAlD
Pravastatin—SLC22A8—head—skin cancer	1.97e-05	0.0198	CbGeAlD
Pravastatin—ABCG2—mammalian vulva—skin cancer	1.96e-05	0.0197	CbGeAlD
Pravastatin—HMGCR—lymph node—skin cancer	1.85e-05	0.0187	CbGeAlD
Pravastatin—SLC16A1—lymph node—skin cancer	1.82e-05	0.0184	CbGeAlD
Pravastatin—CYP2C8—female reproductive system—skin cancer	1.72e-05	0.0174	CbGeAlD
Pravastatin—SLCO2B1—lymph node—skin cancer	1.57e-05	0.0158	CbGeAlD
Pravastatin—CYP2C9—female reproductive system—skin cancer	1.53e-05	0.0154	CbGeAlD
Pravastatin—ABCC2—lymph node—skin cancer	1.34e-05	0.0136	CbGeAlD
Pravastatin—CYP3A4—female reproductive system—skin cancer	1.17e-05	0.0118	CbGeAlD
Pravastatin—CYP2D6—female reproductive system—skin cancer	1.15e-05	0.0116	CbGeAlD
Pravastatin—ABCB1—epithelium—skin cancer	1.11e-05	0.0112	CbGeAlD
Pravastatin—ABCG2—lymph node—skin cancer	9.79e-06	0.00989	CbGeAlD
Pravastatin—ABCB1—mammalian vulva—skin cancer	9.64e-06	0.00973	CbGeAlD
Pravastatin—CYP2D6—head—skin cancer	9.59e-06	0.00968	CbGeAlD
Pravastatin—ABCB1—lymphoid tissue—skin cancer	8.56e-06	0.00864	CbGeAlD
Pravastatin—ABCB1—female reproductive system—skin cancer	8.26e-06	0.00833	CbGeAlD
Pravastatin—ABCB1—head—skin cancer	6.9e-06	0.00696	CbGeAlD
Pravastatin—ABCB1—lymph node—skin cancer	4.83e-06	0.00487	CbGeAlD
